
Enzo Biochem ENZ
Quartalsbericht 2025-Q3
hinzugefügt 30.05.2026
Enzo Biochem DPO 2011-2026 | ENZ
DPO Jährlich Enzo Biochem
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.3 | 74.5 | 112 | 47.3 | 55 | 52.8 | 60 | 62 | 62.9 | 58.4 | 55.5 | 56.5 | 58.8 | 53.3 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 112 | 47.3 | 61.6 |
DPO Vierteljährlich Enzo Biochem
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.1 | 351 | 31.5 | 32.8 | - | 30.2 | 34.6 | 58.1 | - | 209 | 148 | 165 | - | 34.4 | 30.2 | 42 | 22.9 | 44.4 | 53.9 | 44.5 | 27.6 | 44.3 | 50.7 | 49.9 | 21.5 | 50.8 | 48.9 | 53.4 | 28 | 63.5 | - | 58.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 351 | 21.5 | 66.3 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
4.24 K | $ 5.76 | 11.41 % | $ 7.66 M | ||
|
Castle Biosciences
CSTL
|
65.8 | $ 21.68 | 6.33 % | $ 628 M | ||
|
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
196 | - | -61.36 % | $ 2.46 M | ||
|
Fulgent Genetics
FLGT
|
35.2 | $ 19.86 | 9.48 % | $ 611 M | ||
|
Guardant Health
GH
|
48.6 | $ 133.0 | 4.7 % | $ 16.7 B | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
ICON Public Limited Company
ICLR
|
11 | $ 152.75 | 6.15 % | $ 12 B | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 23.0 | 3.09 % | $ 1.23 B | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
Illumina
ILMN
|
57.1 | $ 167.87 | -1.79 % | $ 26 B | ||
|
Interpace Biosciences
IDXG
|
33 | $ 1.79 | 2.29 % | $ 7.92 M | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
Mettler-Toledo International
MTD
|
53.4 | $ 1 178.83 | 0.75 % | $ 24.3 B | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
23.6 | $ 102.5 | 2.24 % | $ 6.92 B | ||
|
NeoGenomics
NEO
|
19.7 | $ 11.47 | 13.12 % | $ 1.47 B | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 186.15 | 3.39 % | $ 9.23 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
Natera
NTRA
|
17.9 | $ 225.67 | 6.52 % | $ 30.9 B | ||
|
Medpace Holdings
MEDP
|
13.3 | $ 457.47 | 1.48 % | $ 13.2 B | ||
|
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
10.1 | $ 19.55 | 2.68 % | $ 438 M | ||
|
Myriad Genetics
MYGN
|
45.9 | $ 4.76 | 8.07 % | $ 441 M | ||
|
Personalis
PSNL
|
65.7 | $ 12.38 | 14.84 % | $ 1.1 B | ||
|
Senseonics Holdings
SENS
|
68 | $ 7.03 | 4.61 % | $ 293 M | ||
|
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
1.44 K | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
32.4 | $ 2.15 | 1.9 % | $ 4.94 M | ||
|
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 260.96 | 0.8 % | $ 21.7 B | ||
|
Twist Bioscience Corporation
TWST
|
12.5 | $ 74.75 | 3.35 % | $ 4.47 B | ||
|
Thermo Fisher Scientific
TMO
|
49.3 | $ 480.69 | 1.4 % | $ 181 B | ||
|
Trinity Biotech plc
TRIB
|
163 | $ 0.68 | -2.84 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 9.13 | 3.58 % | $ 1.98 B | ||
|
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 196.31 | 1.29 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | ||
|
Waters Corporation
WAT
|
102 | $ 377.4 | -0.61 % | $ 22.5 B |